Freemont Management S.A. Organon & Co. Transaction History

Freemont Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$23.4 - $34.25 $1.63 Million - $2.38 Million	69,520 Added 46.63%	218,600 $5.12 Million
Q2 2022 Jul 29, 2022	SELL	$31.66 - $38.9 $240,616 - $295,640	-7,600 Reduced 4.85%	149,080 $5.03 Million
Q1 2022 May 06, 2022	BUY	$30.45 - $39.36 $4.77 Million - $6.17 Million	156,680 New	156,680 $5.47 Million
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $323,397 - $418,826	-11,280 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $320,916 - $428,640	11,280 New	11,280 $341,000

790

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.03B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Freemont Management S.A., based on Form 13F filings with the SEC.

Stay updated on Freemont Management S.A. with notifications on news.